JP
Ju Yeon Park

Established


11
Works
11
Citations
3
H-Index
Search Authors
Author Statistics
  • OpenAlex ID A5048102977
  • i10-Index 0
  • 2-Yr Mean Citedness 0.00
External Links

Ju Yeon Park

Also known as: J. Park, Ji-In Park, Ju Yeon Park

11

Total Works

11

Citations

3

H-Index

0

i10-Index

Citation & Works Trend by Year
7 years active
Top Research Topics
CAR-T cell therapy research (4) T-cell and B-cell Immunology (2) Environmental Toxicology and Ecotoxicology (2) Immunotherapy and Immune Responses (2) Virus-based gene therapy research (2)
Recent Publications
11 shown
Year Publication Title Citations Action
2026 RAM-C analysis based operation field data Journal of the Korea Academia-Industrial cooperation Society 0
2026 Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategy npj Vaccines 0
2025 Endocrine Disruption in Freshwater Cladocerans: Transcriptomic Network Perspectives on TBOEP and PFECHS Impacts in Daphnia magna International Journal of Molecular Sciences 1
2025 CD7 Negative T cells Expressing CD7-CAR (CD7-CARCD7- T cells): Process Development for Clinical-grade Manufacture Cytotherapy 0
2024 A Study on Improving the University Technology Royalty Utilization System through Analytic Hierarchy Process -Focusing on University TLOs- Journal of the Korea Academia-Industrial cooperation Society 0
2024 The Chronic Toxicity of Endocrine-Disrupting Chemical to Daphnia magna: A Transcriptome and Network Analysis of TNT Exposure International Journal of Molecular Sciences 3
2023 Process Development and Manufacturing: DEVELOPMENT OF A CLINICAL-SCALE GMP-COMPLIANT GENE-EDITED CAR T CELL MANUFACTURING PROCESS Cytotherapy 0
2023 Process Development and Manufacturing: PREPARATION OF CRYOPRESERVED CAR T CELLS FOR NEURAL AXIS INFUSION Cytotherapy 0
2021 Development of a cgmp-compliant process to manufacture donor-derived, CD45RA-depleted memory cd19- car T-Cells Cytotherapy 0
2017 Design of an enhanced defect identification system for commercial building construction Systems and Information Engineering Design Symposium 4
2007 A phase I trial of vorinostat in children with refractory solid tumors: A Children's Oncology Group Study Journal of Clinical Oncology 3

Data source: OpenAlex API